Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kanghai Pharmaceutical Technology Development is a comprehensive contract research organization (CRO) and pharmaceutical technology firm headquartered in Beijing, China. Founded in 2003, the company offers a full suite of services encompassing drug discovery, preclinical research, clinical trial coordination, and regulatory registration. Their expertise spans across chemical drugs, biological agents, and traditional Chinese medicine (TCM). Kanghai is particularly noted for its ability to facilitate technology transfers and provide strategic consulting for companies entering the Chinese pharmaceutical market. The organization maintains a strong focus on quality control and regulatory compliance to meet international standards. It serves as a bridge for global pharmaceutical innovation within the Chinese regulatory landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kang Hai Pharmaceutical Technology Development.